Indefinite Delivery Contract 19AQMM23D0093

Award Date 9/30/23
Last Date to Order 9/29/28
Funding Federal Agency
Bureau of Medical Services
Contracting Federal Agency
Office of Acquisition Management
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract, awarded by the Defense Logistics Agency Troop Support Medical, provides for the delivery of various medical products and treatments to the U.S. government. The prime contractor is Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract, valued at up to $597 million, has a period of performance from January 1, 2013 to December 31, 2014. It does not utilize any set-aside designations. Meridian has been awarded multiple delivery...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The IDC has a ceiling value of $4,999,999 and runs through November 23, 2025, allowing the DLA to efficiently procure a wide range of pharmaceutical products and medical supplies to support military healthcare needs nationwide. The contract involves the delivery of critical care...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at up to $999,999,999.00 through December 2025, is intended to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contracted items include specialty medications, brand-name and generic drugs, vaccines, and critical...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation, as the sole prime contractor. The $999,999,999.00 single-award IDC has an ultimate completion date of December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
This federal Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC, awarded on June 22, 2020, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $999,999,999 through December 2025, is for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract is not set-aside and was awarded through full...
This Indefinite Delivery Contract (IDC) with ID SPE2DB20D1004 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and...
The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at up to $499,999,999, runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $999,999,999.00, provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. Under this single-award IDC, Amerisourcebergen fulfills numerous delivery orders from the DLA for...
This indefinite delivery contract (IDC) was awarded by the U.S. Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $500 million single-award IDC, with a period of performance from January 2005 through March 2015, serves as the primary vehicle for Amerisourcebergen to deliver specialty...
  • 19AQMM23D0093
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

This indefinite delivery contract (IDC) awarded by the Department of State Bureau of Medical Services to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., provides for the delivery of autoinjectors and associated training devices to Department of State personnel globally. The single-award $100 million, 5-year "MANDRAKE 3.0 IDIQ" contract does not utilize any small business set-asides. An initial $17,955,751.55 firm fixed-price delivery order was issued to Meridian at the time of award for autoinjectors and trainers, with a period of performance through October 2024. Meridian Medical Technologies has an established history of providing medical countermeasures such as nerve agent antidote treatments and training devices to various federal agencies, including the Department of Defense and Department of Veterans Affairs. This IDC award further solidifies Meridian's position as a key provider of autoinjector devices and associated services to the federal government.

In addition to the initial $17.9 million delivery order, Meridian Medical Technologies recently received a $9.9 million definitive contract from the Department of Health and Human Services for the emergency procurement of 140,010 DuoDote single dose autoinjectors to replenish the Strategic National Stockpile inventory. These large IDIQ and definitive contract awards underscore Meridian's expertise and capabilities in the development and manufacturing of critical medical devices and countermeasures for the federal sector.

Generated 9/15/24, 9:04 AM